🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06719739
Recruiting Not applicable

Functional IOL Implantation in Patients With Epiretinal Membrane

NCT06719739 · tracked via the Priya Life Science China tracker
Sponsor
Eye & ENT Hospital of Fudan University
Phase
Not applicable
Started
2024-09-21
Last updated
2026-04-08

Condition(s) studied

CataractIntraocular Lens ComplicationEpiretinal Membrane

Investigational drug(s) / intervention(s)

Intraocular lens implantation

Intraocular lens implantation: Cataract patients scheduled for surgery will be evaluated by OCT, and those diagnosed with macular epiretinal membrane will be implanted in different IOLs according to the patients' decision: monodical IOL or functional IOL.

Study summary

We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.

Eligibility

Sex
ALL
Min age
20 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Requirement for cataract extraction * Age \> 40 years * Axial length in 21mm to 25mm * ERM Exclusion Criteria: * Residual corneal astigmatism \> 1.0 D * Amblyopia * Previous ocular surgery * Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular degeneration, glaucoma with field defects * Requirements for further ocular surgery (other than Nd:YAG capsulotomy) or retinal laser treatments during the study

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Eye and Ear, Nose, and Throat Hospital of Fudan University Shanghai Shanghai Municipality Recruiting
Shanghai Heping Eye Hospital Shanghai Shanghai Municipality Recruiting

More Eye & ENT Hospital of Fudan University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06719739 on ClinicalTrials.gov ↗ ← All trials in China